Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy

Journal of Biological Regulators and Homeostatic Agents

Volumn 27, Issue 3, 2013, Pages 693-703

  Eid, S ^a   Abou Kheir, W ^a   Sabra, R ^a   Daoud, G ^a   Jaffa, A ^a   Ziyadeh, F N ^a   Roman, L ^b   Eid, Assaad A ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b University of Texas Health Science Center   (United States)

Author keywords

20 HETE; Cytochromes P450; Diabetic nephropathy; NADPH oxidase; Reactive oxygen species; TGF

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; CYTOCHROME P450; CYTOCHROME P450 4A; CYTOCHROME P450 INHIBITOR; EPOXYICOSATRIENOIC ACID; FIBRONECTIN; GLUCOSE; HET 0016; INSULIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STREPTOZOCIN; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; ALKANE 1 MONOOXYGENASE; HYDROXYICOSATETRAENOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; FATTY ACID METABOLISM; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERGLYCEMIA; HYPERTENSION; KIDNEY HYPERTROPHY; KIDNEY MASS; KIDNEY MICROSOME; MALE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; ANIMAL; BIOSYNTHESIS; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; METABOLISM; PATHOLOGY; PHYSIOLOGY; COMPLICATION; DIABETIC NEPHROPATHIES;

ALKANE 1-MONOOXYGENASE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HYDROXYEICOSATETRAENOIC ACIDS; KIDNEY; MALE; NADPH OXIDASE; RATS; REACTIVE OXYGEN SPECIES; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1; CYTOCHROME P-450 CYP4A;

EID: 84891604983     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bilous RW, Mauer SM, Sutherland DE, Steffes MW. Mean glomerular volume and rate of development of diabetic nephropathy. Diabetes 1989; 38(9):1142-7.
2. Fogo A, Ichikawa I. Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis. Am J Kidney Dis 1991; 17(6):666-9.
3. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 1995; 47(3):935-44.
4. McCarthy ET, Sharma R, Sharma M. Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier. Kidney Int 2005; 67(1):152-6.
5. Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL, Block K, Abboud HE. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 2009; 58(5):1201-11.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414(6865):813-20.
7. Puntarulo S, Cederbaum AI. Production of Reactive Oxygen Species by Microsomes Enriched in Specific Human Cytochrome P450 Enzymes. Free Radic Biol Med 1998; 24(7-8):1324.
8. Fleming I, Michaelis UR, Bredenkötter D, Fisslthaler B, Dehghani F, Brandes RP, Busse R. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circulation Res 2001; 88(1):44-51.
9. Carroll MA, McGiff JC. A new class of lipid mediators: cytochrome P450 arachidonate metabolites. Thorax 2000; 55(2):13-6.
10. Wang Z, Tang X, Li Y, Leu C, Guo L, Zheng X, Zhu D. 20- Hydroxyeicosatetraenoic acid inhibits the apoptotic responses in pulmonary artery smooth muscle cells. Eur J Pharmacol 2008; 588(1):9-17.
11. Guo AM, Arbab AS, Falck JR, Chen P, Edwards PA, Roman RJ, Scicli AG. Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation. J Pharmacol Exp Ther 2007; 321(1):18-27.
12. Holla VR, Adas F, Imig JD, et al. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proceedings of the National Academy of Sciences of the United States of America 2001; 98(9):5211-6.
13. Schwartzman ML, a Silva JL, Lin F, Nishimura M, Abraham NG. Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat. Nephron 1996; 73(4):652-63.
14. Christmas P, Jones JP, Patten CJ, et al. Alternative Splicing Determines the Function of CYP4F3 by Switching Substrate Specificity. J Biol Chem 2001; 276(41):38166-72.
15. Eid AA, Ford BM, Block K, Kasinath BS, Gorin Y, Ghosh-Choudhury G, Barnes JL, Abboud HE. AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem 2010; 285(48):37503-12.
16. Maalouf RM, Eid AA, Gorin YC, Block K, Escobar GP, Bailey S, Abboud HE. Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes. Am J Physiol Cell Physiol 2012; 302(3):C597-604.
17. Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 1999; 56:393-405.
18. Baynes JW. Role of Oxidative Stress in Development of Complications in Diabetes. Diabetes 1991; 40(4):405-12.
19. Ha H, Kim C, Son Y, Chung MH, Kim KH. DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic Biol Med 1994; 16:271-4.
20. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney Int 2002; 61:186-94.
21. Kuroki T, Isshiki K, King GL. Oxidative Stress: The Lead or Supporting Actor in the Pathogenesis of Diabetic Complications. J Am Soc Nephrol 2003; 14(3)216-20.
22. Cui XL, Douglas JG. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc Natl Acad Sci USA 1997; 94(8):3771-76.
23. Geiszt M, Leto TL. The Nox family of NAD(P) H oxidases: host defense and beyond. J Biol Chem 2004; 279:51715-18.
24. Jones SA, Hancock JT, Jones OT, Neubauer A, Topley N. The Expression of NADPH Oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67 phox, and p22phox. J J Am Soc Nephrol 1995; 5:1483-91.
25. Nilakantan V, Maenpaa C, Jia G, Roman RJ, Park F. 20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells. Am J Physiol Renal Physiol 2008; 294:562-70.
26. Baliga R, Zhang Z, Shah SV. Role of cytochrome P-450 in hydrogen peroxide-induced cytotoxicity to LLC-PK1 cells. Kidney Int 1996; 50:1118-24.
27. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Natl Acad Sci USA 1993; 90:1814-8.
28. Zhu Y, Usui HK, Sharma K. Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment. Semin Nephrol 2007; 27:153-160.
29. Dahly-Vernon AJ, Sharma M, McCarthy ET, Savin VJ, Ledbetter SR, Roman RJ. Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats. Hypertension 2005; 45:643-8.
30. Liang CJ, Ives HE, Yang CM, Ma YH. 20-HETE inhibits the proliferation of vascular smooth muscle cells via transforming growth factor-beta. J Lipid Res 2008; 49(1):66-73.